Objective To explore the risk factors for early dysfunction of arteriovenous fistula (AVF) in maintenance hemodialysis (MHD) patients. Methods A total of 128 patients who underwent the first AVF creation surgery from January 2017 to February 2020 in the single center were enrolled in this study. Based on the diagnosis criteria of AVF failure and the AVF patency duration, patients were divided into one-year failure group, one-year non-failure group, 2-year failure group and 2-year non-failure group. The differences in clinical data between failure groups and non-failure groups were retrospectively analyzed. Results Multivariate COX regression revealed that lower hemoglobin (OR=4.729, 95% CI: 1.108～20.188, P=0.036), lower platelet (OR=0.980, 95% CI: 0.967～0.993, P=0.003), lower blood glucose (OR=0.665, 95% CI: 0.449～0.986, P=0.042), older age (OR=1.051, 95% CI: 1.001～1.102, P=0.044) and female (OR=6.468, 95% CI: 1.458～28.689, P=0.014) were the risk factors for AVF failure in one year; older age (OR=1.042, 95% CI: 1.001～1.085, P=0.046), lower hemoglobin (OR=0.948, 95% CI: 0.912～0.986, P=0.007), lower platelet (OR=0.986，95% CI: 0.976～0.997, P=0.009) and lower blood glucose (OR=0.632, 95% CI: 0.419～0.953, P=0.029) were the risk factors for AVF failure in two years. Kaplan-Meier survival curve demonstrated that the AVF patency duration was significantly shorter in patients over 60 years old than in those <60 years old (log-rank, c2=6.253, P=0.012), and was shorter in females than in males (log-rank, c2=9.387, P=0.002). Conclusion Older age, female, lower hemoglobin, lower platelet, and lower blood glucose were the risk factors for early failure of AVF in MHD patients.
YANG Xiao-Lin
,
WANG Ying-Deng
,
ZHUANG Feng
,
XIAN Shu-Li
. The influencing factors for early failure of arteriovenous fistula in maintenance hemodialysis patients[J]. Chinese Journal of Blood Purification, 2023
, 22(11)
: 871
-875
.
DOI: 10.3969/j.issn.1671-4091.2023.11.016
[1]Pisoni RL, Zepel L, Port FK, et al.Trends in US Vascular Access Use,Patient Preferences,and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons[J].American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 2015, 65(6):905-915
[2]Perl J, Karaboyas A, Morgenstern H, et al.Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS[J].Nephrol Dial Transplant, 2017, 32(3):521-527
[3]中国医院协会血液净化中心管理分会血液净化通路学组.中国血液透析用血管通路专家共识第版[J].中国血液净化, 2014, 13(8):549-558
[4]Malik J, de Bont C, Valerianova A, et al.Arteriovenous Hemodialysis Access Stenosis Diagnosed by Duplex Doppler Ultrasonography: A Review[J]. Diagnostics (Basel), 2022, 12(8):1979-1979
[5]Pisoni RL, Zepel L, Zhao J, et al.International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS)[J].Am J Kidney Dis, 2021, 77(2):245-254
[6]Huber TS, Berceli SA, Scali ST, et al.Arteriovenous Fistula Maturation,Functional Patency,and Intervention Rates[J].JAMA Surg, 2021, 156(12):1111-1118
[7]Stolic RV, Trajkovic GZ, Kostic M, et al.Predictive value of serum myeloperoxidase activity for thrombosis of arteriovenous fistulas[J].Hemodial Int, 2014, 18(3):680-685
[8]Farber A, Imrey PB, Huber TS, et al.Multiple preoperative and intraoperative factors predict early fistula thrombosis in the Hemodialysis Fistula Maturation Study[J].J Vasc Surg, 2016, 63(1):163-170
[9]王立华, 姜埃利, 魏芳.动静脉内瘘建立后的血流动力学变化[J].中华肾脏病杂志, 2015, 31(10):797-800
[10]Waheed A, Masengu A, Skala T, et al.A prospective cohort study of predictors of upper extremity arteriovenous fistula maturation[J].J Vasc Access, 2020, 21(5):746-752
[11]Bashar K, Conlon PJ, Kheirelseid EA, et al.Arteriovenous fistula in dialysis patients: Factors implicated in early and late AVF maturation failure[J].Surgeon, 2016, 14(5):294-300
[12]Viecelli AK, Lok CE.Hemodialysis vascular access in the elderly-getting it right[J].Kidney Int, 2019, 95(1):38-49
[13]Bylsma LC, Gage SM, Reichert H, et al.Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes[J].Eur J Vasc Endovasc Surg, 2017, 54(4):513-522
[14]Chantrel F, Sissoko H, Képénékian L, et al.Influence of dialysis on the glucose profile in patients with diabetes: usefulness of continuous glucose monitoring[J].Horm Metab Res, 2014, 46(11):810-813
[15]Park J, Lertdumrongluk P, Molnar MZ, et al.Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon[J].Curr Diab Rep, 2012, 12(4):432-439
[16]郑雯雯, 鲁春红, 戴小梅.维持性血液透析患者自体动静脉内瘘失功危险因素的分析[J].中国血液净化, 2019, 18(10):705-709
[17]Kim S, Molnar MZ, Fonarow GC, et al.Mean platelet volume and mortality risk in a national incident hemodialysis cohort[J].Int J Cardiol , 2016, 220(1;220):862-870
[18]汤立, 侯建全, 戴兰, et al.血小板活化指标CD62P、CD63和PAC-1在血透患者自身动静脉内瘘反复失功中的意义[J]. , (05):.[J].苏州大学学报(医学版), 2008, 5: 785-788
[19]Aitken E, Jackson A, Kong C, et al.Renal function, uraemia and early arteriovenous fistula failure[J]., 2014, 15:179.-179.
[20]张炜晨, 张敏敏, 王梦婧, et al.维持性血液透析患者自体动静脉内瘘血管钙化的研究进展[J].中华肾脏病杂志, 2018, 5:391-395
